Manager × security

Krensavage Asset Management, LLC UTHR holdings history

Who else holds this security? →

UNITED THERAPEUTICS CORP · CUSIP 91307C102 · CIK 1609251

Some filings reported values in thousands; those figures were scaled ×1000 to dollars.
This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Krensavage Asset Management, LLC reported 69.28K UTHR (shares), valued at $37.54M, or 14.26% of its reported non-derivative portfolio. Filed 2026-08-14.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
14.26%
Shares
69.28K
69,282
Reported value
$37.54M
USD

Shares decreased 17.80%; reported value decreased 24.89%, and weight changed -5.29 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 202614.26%69,282SEC filing ↗Filed Aug 14, 2026
Q1 202619.55%84,282SEC filing ↗Filed May 15, 2026
Q4 202515.71%91,282SEC filing ↗Filed Feb 18, 2026
Q3 202517.44%97,646SEC filing ↗Filed Nov 17, 2025
Q2 202515.38%101,146SEC filing ↗Filed Aug 15, 2025
Q1 202516.74%98,228SEC filing ↗Filed May 15, 2025
Q4 202419.22%92,057SEC filing ↗Filed Feb 18, 2025Amended
Q3 202420.15%100,332SEC filing ↗Filed Nov 15, 2024
Q2 202417.29%118,208SEC filing ↗Filed Aug 15, 2024
Q1 202415.96%156,714SEC filing ↗Filed May 15, 2024
Q4 202315.67%200,872SEC filing ↗Filed Feb 14, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 202315.67%200,872$44.17MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 14, 2024
Q1 202415.96%156,714$36.00MShares decreased 21.98%; reported value decreased 18.50%, and weight changed +0.29 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2024
Q2 202417.29%118,208$37.66MShares decreased 24.57%; reported value increased 4.60%, and weight changed +1.33 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 15, 2024
Q3 202420.15%100,332$35.95MShares decreased 15.12%; reported value decreased 4.52%, and weight changed +2.86 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 15, 2024
Q4 202419.22%92,057$32.48MShares decreased 8.25%; reported value decreased 9.66%, and weight changed -0.93 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 18, 2025
Q1 202516.74%98,228$30.28MShares increased 6.70%; reported value decreased 6.77%, and weight changed -2.48 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2025
Q2 202515.38%101,146$29.06MShares increased 2.97%; reported value decreased 4.02%, and weight changed -1.36 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 15, 2025
Q3 202517.44%97,646$40.93MShares decreased 3.46%; reported value increased 40.84%, and weight changed +2.06 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Nov 17, 2025
Q4 202515.71%91,282$44.48MShares decreased 6.52%; reported value increased 8.66%, and weight changed -1.73 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 18, 2026
Q1 202619.55%84,282$49.98MShares decreased 7.67%; reported value increased 12.37%, and weight changed +3.84 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed May 15, 2026
Q2 202614.26%69,282$37.54MShares decreased 17.80%; reported value decreased 24.89%, and weight changed -5.29 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Aug 14, 2026
Krensavage Asset Management, LLC · UNITED THERAPEUTICS CORP

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1609251","quarter":"2026Q2","cusip":"91307C102"}

get_institutional_manager_history
{"cik":"1609251","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.